Physician

Adnan Ahmed, M.D.

According to 2025 Medicare claims, Adnan Ahmed, M.D. (NPI: 1811972789) practices nephrology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is KIDNEY & HYPERTENSION SPECIALISTS OF CENTRAL FLORIDA (NPI: 1215912167; TIN: 59-3725484) and primary practice location at 34715-7434. Ahmed is affiliated with the Primary Care Alliance, LLC (ACO ID: D0010) and American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Ahmed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 415 traditional Medicare patients, billed 3,869 HCPCS/CPT codes, and received $281,707 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 3,513 prescription claims across 578 beneficiaries totaling $506,017 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 50 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $732,521 to $506,017. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	600	2,507	$271,006
2016	598	2,576	$272,440
2017	674	2,980	$310,693
2018	635	2,489	$263,996
2019	642	2,703	$300,639
2020	671	2,644	$303,836
2021	576	2,332	$298,652
2022	528	1,998	$252,886
2023	487	2,154	$233,200
2024	415	3,869	$281,707

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	572	4,367	$732,521
2016	596	4,780	$1,116,740
2017	669	4,548	$1,162,047
2018	698	4,112	$777,432
2019	683	3,395	$661,920
2020	717	3,859	$833,563
2021	632	3,447	$699,378
2022	580	3,163	$551,031
2023	557	3,154	$581,003
2024	578	3,513	$506,017

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	115	$7,016
2016	N/R	140	$5,797
2017	N/R	72	$2,795
2018	N/R	101	$4,477
2019	N/R	78	$6,461
2020	N/R	43	$1,256
2021	N/R	15	$566
2022	N/R	38	$694
2023	N/R	50	$815
2024	N/R	50	$737

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	86	382	$272
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	65	109	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	115	427	$60
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	87	131	$53
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	193	355	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	57	2,025	$177,465
Farxiga	Dapagliflozin Propanediol	62	4,545	$79,991
Sevelamer Carbonate	Sevelamer Carbonate	186	8,831	$44,461
Jardiance	Empagliflozin	18	1,500	$28,345
Lanthanum Carbonate	Lanthanum Carbonate	32	1,140	$25,244

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$204
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	13	$163
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	13	$143

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Adnan Ahmed, M.D.?

Tedicare shows public-source Medicare data for Adnan Ahmed, M.D. (NPI 1811972789), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adnan Ahmed, M.D. have ACO affiliation data?

Adnan Ahmed, M.D. is shown with ACO affiliation data for Primary Care Alliance, LLC (REACH, ACO ID D0010) and American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Adnan Ahmed, M.D.?

Adnan Ahmed, M.D. is linked to KIDNEY & HYPERTENSION SPECIALISTS OF CENTRAL FLORIDA (billing NPI 1215912167) in the available physician profile data.

Does Adnan Ahmed, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.